The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Doumani Roy since year 2005.
The trader's CIK number is 1230232.
At the time of this reporting, Doumani Roy is the Director of Kite Pharma, Inc. .
(stock ticker symbol KITE).
See this page for all insider trading activities at Kite Pharma, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-06-08||KITE||Kite Pharma, Inc.||Sale||5,000||84.53||422,635|
|2017-06-07||KITE||Kite Pharma, Inc.||Sale||10,000||84.46||844,620|
|2017-03-01||KITE||Kite Pharma, Inc.||Sale||18,800||75.36||1,416,674|
|2017-03-01||KITE||Kite Pharma, Inc.||Option Ex||50,000||1.35||67,500|
|2016-06-06||KITE||Kite Pharma, Inc.||Sale||14,000||58.06||812,896|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Doumani Roy (Director of Kite Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.